Scarica l'app Stockscreener
2.75
2.83%
-0.08
Dopo l'orario di chiusura:
2.71
-0.04
-1.45%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.83
Aprire:
$2.76
Volume 24 ore:
399.34K
Relative Volume:
1.43
Capitalizzazione di mercato:
$93.56M
Reddito:
$210.00K
Utile/perdita netta:
$-10.12M
Rapporto P/E:
-9.0699
EPS:
-0.3032
Flusso di cassa netto:
$-7.12M
1 W Prestazione:
-9.84%
1M Prestazione:
-15.38%
6M Prestazione:
-7.72%
1 anno Prestazione:
-8.94%
Intervallo 1D:
$2.66
$2.8085
Intervallo di 1 settimana:
$2.66
$3.20
Portata 52W:
$2.32
$5.4566
Anixa Biosciences Inc Stock (ANIX) Company Profile
Nome
Anixa Biosciences Inc
Settore
Industria
Telefono
408-708-9808
Indirizzo
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE
Compare ANIX vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ANIX
Anixa Biosciences Inc
|
2.75 | 96.29M | 210.00K | -10.12M | -7.12M | -0.3032 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Anixa Biosciences Inc Stock (ANIX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-21 | Iniziato | Maxim Group | Buy |
| 2022-12-23 | Iniziato | Chardan Capital Markets | Buy |
| 2021-04-12 | Iniziato | H.C. Wainwright | Buy |
Anixa Biosciences Inc Borsa (ANIX) Ultime notizie
Anixa advances ovarian cancer CAR-T trial to highest dose level - scanx.trade
Anixa Biosciences Q3 Results: EPS beats estimate, sales flat - scanx.trade
Anixa Biosciences secures Australian patent for breast cancer vaccine - scanx.trade
Anixa Biosciences (NASDAQ:ANIX) Issues Quarterly Earnings Results - MarketBeat
Anixa Biosciences Inc reports results for the quarter ended July 31Earnings Summary - TradingView
Anixa Biosciences highlights progress in breast cancer vaccine on Bloomberg TV this Saturday. - Pluang
A breast cancer survivor will discuss Anixa's vaccine on TV - Stock Titan
Anixa Biosciences Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
Anixa Biosciences to Present at the Nasdaq & LD Micro Inaugural SF Summit on September 9, 2026 - PR Newswire
Anixa Biosciences (ANIX) Projected to Post Earnings on Wednesday - MarketBeat
Anixa Biosciences Inc. (ANIX) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Anixa Biosciences Inc. (ANIX) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Anixa Biosciences Inc (NASDAQ:ANIX) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Anixa Biosciences to Present at the 2026 Cantor Fitzgerald Global Healthcare Conference Highlighting its Breast Cancer Vaccine and Ovarian Cancer CAR-T Therapy - AOL.ca
Breast cancer vaccine meets Phase 1 goals; ovar... - Pluang
Anixa Biosciences (NASDAQ:ANIX) Stock Rating Lowered by Zacks Research - MarketBeat
Spotlighting Anixa Biosciences And 2 Other Noteworthy Penny Stocks - Sahm
Anixa (ANIX) Range: Slides 2.70% to $3.61 in the Latest Reading; Level Watch - vinanet.vn
Anixa (ANIX) Latest Results Brief: EPS Prints Above Forecast at the Close; Post-Earnings Trading: Shares Finish 3.30% Lower in the Latest ReadingEBITDA Analysis - vinanet.vn
Anixa Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference - PR Newswire
Anixa to present cancer data: longest survival is about 28 months - Stock Titan
Anixa Biosciences (ANIX) Surges 7.7% as Biotech Momentum BuildsCorrective Wave - vinanet.vn
Anixa Biosciences (ANIX) Slips 0.63% to $3.18 as Shares Consolidate Between Key Support and ResistancePre-Earnings Momentum - vinanet.vn
ANIX Q2 2026 Earnings: Narrower Loss of $0.07 per Share Beats Estimates Amid Steady Pipeline Execution - vinanet.vn
Anixa Biosciences (ANIX) Holds Near $3.42 as Traders Eye Key Support and Resistance LevelsVolatility Term Structure - vinanet.vn
Anixa Biosciences (NASDAQ:ANIX) CEO Amit Kumar Buys 5,000 Shares - MarketBeat
Anixa Biosciences (ANIX) CEO Amit Kumar Buys 5,000 Shares, Insider Ownership Climbs to 657,000 Shares - GuruFocus
Anixa Biosciences CEO Amit Kumar buys $17,350 in company stock By Investing.com - Investing.com Nigeria
Form 4 Anixa Biosciences Inc For: 3 August By Investing.com - Investing.com Nigeria
Anixa Biosciences (ANIX) CEO purchases 5,000 company shares - Stock Titan
Anixa Biosciences Inc (NASDAQ:ANIX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Form 4 Anixa Biosciences Inc For: 29 July By Investing.com - Investing.com Nigeria
Anixa Biosciences (ANIX) director exercises 6,000 options, uses 5,428 shares to pay cost - Stock Titan
Anixa Biosciences (NASDAQ:ANIX) CEO Acquires $17,200.00 in Stock - MarketBeat
Anixa Biosciences (NASDAQ:ANIX) CEO Acquires 3,000 Shares - MarketBeat
Anixa Biosciences (NASDAQ: ANIX) CEO buys 5,000 shares, now holds 652,000 - Stock Titan
Anixa Biosciences Inc (ANIX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Form 4 Anixa Biosciences Inc For: 27 July By Investing.com - Investing.com Nigeria
Anixa Biosciences (ANIX) CEO purchases 3,188 shares at $3.37 each - Stock Titan
Anixa Biosciences CEO Amit Kumar buys $11,190 in company stock - Investing.com
Anixa Biosciences CEO Amit Kumar buys $11,190 in company stock By Investing.com - Investing.com Canada
Anixa Biosciences Inc (ANIX) CEO purchases 3,000 shares at $3.73 - Stock Titan
Anixa Biosciences Inc (ANIX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Anixa Biosciences Inc (ANIX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Anixa Biosciences, Inc. Revenue Breakdown – NASDAQ:ANIX - TradingView
Anixa Biosciences Inc (ANIX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
ANIX|Anixa Biosciences Inc|Price:3.700|Chg%:-0.050 - TradingKey
TradingKey - TradingKey
Anixa Biosciences Inc (ANIX) Valuation: PE, PB & Fair Value Analysis - TradingKey
ANIX|Anixa Biosciences Inc|Price:3.725|Chg%:+0.025 - TradingKey
ANIX|Anixa Biosciences Inc|Price:3.680|Chg%:-0.020 - TradingKey
Anixa Biosciences Inc Azioni (ANIX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):